SYNERGY
3006366.710.45% ( +0.03 )
SYNERGY (300636)
Jiangxi Synergy Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of active pharmaceutical in...
- Open
- 6.66
- High
- 6.75
- Low
- 6.64
- Prev. Close
- 6.68
- Volume
- 54.03K
- Turnover
- 36.15M
- Avg Price
- 6.69
- Bid/Ask Ratio
- --
- Amplitude
- 1.65%
- 52wk High
- 9.44
- Volume Ratio
- 0.75
- Turnover Ratio
- 1.29%
SYNERGY Analyst Rating
View MoreForecast & Rating
Jun 8, 2026Price forecast
¥8.5026.49%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Nov 3, 2025 at 02:53 AM
SYNERGY passed the on-site inspection by the U.S. FDA
- Zhitong · Sep 16, 2025 at 03:57 AM
SYNERGY has obtained the European Pharmacopoeia Adaptation Certificate
- Zhitong · Sep 1, 2025 at 12:38 AM
SYNERGY: CMO/CDMO business is expected to achieve rapid growth in 2027 and 2028
- Zhitong · Aug 14, 2025 at 03:22 AM
SYNERGY: The raw material drug Amlodipine Besylate has passed the GMP compliance inspection
- Zhitong · Jul 22, 2025 at 04:45 AM
SYNERGY: Agomelatine and Opicapone have obtained drug registration certificates in South Korea
- Zhitong · Jun 26, 2025 at 08:01 PM
Zhitong A-shares lock-up release overview | June 27
